Charle Co.,Ltd.
Charle Co.,Ltd. (9885.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Charle Co.,Ltd. (9885.T), featuring income statements, balance sheets, and cash flow data.
Charle Co.,Ltd. (9885.T) Income Statement & Financial Overview
Review Charle Co.,Ltd. 9885.T income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.38B | $3.45B | $3.06B | $2.65B |
| Cost of Revenue | $1.46B | $1.88B | $1.68B | $1.45B |
| Gross Profit | $924.00M | $1.57B | $1.38B | $1.20B |
| Gross Profit Ratio | $0.39 | $0.46 | $0.45 | $0.45 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $1.61B | $1.54B | $1.49B | $1.40B |
| Operating Expenses | $1.61B | $1.54B | $1.48B | $1.40B |
| Total Costs & Expenses | $3.07B | $3.42B | $3.16B | $2.86B |
| Interest Income | $7.00M | $0.00 | $0.00 | $1.00M |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $180.00M | $119.25M | $110.50M | $119.25M |
| EBITDA | -$524.00M | $152.25M | $8.50M | -$86.75M |
| EBITDA Ratio | -$0.22 | $0.04 | $0.003 | -$0.03 |
| Operating Income | -$686.00M | $32.00M | -$101.00M | -$206.00M |
| Operating Income Ratio | -$0.29 | $0.009 | -$0.03 | -$0.08 |
| Other Income/Expenses (Net) | -$16.00M | $5.00M | $3.00M | $4.00M |
| Income Before Tax | -$702.00M | $37.00M | -$98.00M | -$202.00M |
| Income Before Tax Ratio | -$0.29 | $0.01 | -$0.03 | -$0.08 |
| Income Tax Expense | $33.00M | $6.00M | $4.00M | $12.00M |
| Net Income | -$735.00M | $31.00M | -$94.00M | -$214.00M |
| Net Income Ratio | -$0.31 | $0.009 | -$0.03 | -$0.08 |
| EPS | -$47.07 | $1.99 | -$5.97 | -$13.51 |
| Diluted EPS | -$47.07 | $1.99 | -$5.97 | -$13.51 |
| Weighted Avg Shares Outstanding | $15.61M | $15.61M | $15.75M | $15.84M |
| Weighted Avg Shares Outstanding (Diluted) | $15.61M | $15.61M | $15.75M | $15.84M |
Over the past four quarters, Charle Co.,Ltd. demonstrated steady revenue growth, increasing from $2.65B in Q1 2024 to $2.38B in Q4 2024. Operating income reached -$686.00M in Q4 2024, maintaining a consistent -29% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$524.00M, reflecting operational efficiency. Net income dropped to -$735.00M, with EPS at -$47.07. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan